ROBAEYS, Geert

Email Alert RSS Feed

Profile

Full Name
ROBAEYS, Geert
Email
geert.robaeys@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  ROBAEYS, Geert
Author:  Bourgeois, S.

Results 1-12 of 12 (Search time: 0.005 seconds).

Issue DateTitleContributor(s)TypeCat.
12021Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium : an observational studyBourgeois, S.; Mulkay, J. P.; Cool, M.; Verhelst, X.; ROBAEYS, Geert; Lasser, L.; Lefebvre, V; Colle, I; Van Steenkiste, C.; Decaestecker, J.; Coulon, S.; VENKEN, Koen; Vanwolleghem, T.Journal ContributionA1
22019Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysisMuyldermans, G.; BIELEN, Rob; Botterman, R.; Bourgeois, S.; Colle, I; Deressa, B.; Devolder, G.; Horsmans, Y.; Hutse, V; Lanthier, N.; Lasser, L.; Platteau, S.; ROBAEYS, Geert; Suin, V; Verhelst, X.; Van Vlierberghe, H.; Van Baelen, L.Journal ContributionA1
32019A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016Bourgeois, S.; Mulkay, J. P.; Lasser, L.; ROBAEYS, Geert; Bastens, B.; Delwaide, J.; Pollet, S.; Van den Enden, M.Journal ContributionA1
42019Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groupsOpstaele, L.; BIELEN, Rob; Bourgeois, S.; Moreno, C.; Nevens, F; ROBAEYS, Geert; Van Vlierberghe, H.Journal ContributionA1
52018Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesVan Hees, S.; Bourgeois, S.; Van Vlierberghe, Hans; Serste, T.; Francque, S.; Michielsen, P.; Sprengers, D.; Reynaert, H.; Henrion, J.; Dastis, S. Negrin; Delwaide, J.; Lasser, L.; Decaestecker, J.; Orlent, H.; Janssens, F.; ROBAEYS, Geert; Colle, I.; Starkel, P.; Moreno, C.; Nevens, F.; Vanwolleghem, T.Journal ContributionA1
62017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
72017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experienceBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
82017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Francque, S.; Verlinden, W.; Brixko, C.; Decaestecker, J.; De Galocsy, C.; Janssens, F.; Cool, M.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionM
92017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Vanwolleghem, T.; Verlinden, W.; Brixco, C.; Decaestecker, J.; de Galocsy, C.; Janssens, F.; Van Overbeke, L.; Van Steenkiste, C.; D'Heygere, F.; Cool, M.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
102016Belgian Experience with Direct Acting Antivirals in People Who Inject DrugsBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cools, Mario; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; COOLS, Wilfried; Nevens, F.; ROBAEYS, GeertConference MaterialC2
112016Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsARAIN, Amber; Bourgeois, S.; de Galocsy, C.; Henrion, J.; Deltenre, P.; d'Heygere, F.; George, C.; Bastens, B.; Van Overbeke, L.; Verrando, R.; BRUCKERS, Liesbeth; Mathei, Catharina; Buntinx, F.; Van Vlierberghe, H.; Francque, S.; Laleman, W.; Moreno, C.; Janssens, F.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
122015Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCD genotype 2/3 infection: the activate studyGrebely, J.; Dalgard, O.; Conway, B.; Foster, G.; Bruggmann, P.; Backmund, M.; ROBAEYS, Geert; Swan, T.; Hajarizadeh, B.; Amin, J.; Marks, P.; Quiene, S.; Weltman, M.; Shaw, D.; Dunlop, A.; Hellard, M.; Bruneau, J.; Bourgeois, S.; Thurnheer, C.; Dore, G. J.Journal ContributionM